Perrigo Company PLC
NYSE:PRGO
Perrigo Company PLC
NYSE:PRGO
Price:
9.69
USD
0.52%
Market Closed
Market Cap:
$1.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Perrigo Company PLC
NYSE:PRGO
|
IE |
|
Engie Brasil Energia SA
BOVESPA:EGIE3
|
BR |
|
T
|
Tirathai PCL
SET:TRT
|
TH |
|
O
|
Onewo Inc
HKEX:2602
|
CN |
|
Tinka Resources Ltd
XTSX:TK
|
CA |
|
Luzhou Laojiao Co Ltd
SZSE:000568
|
CN |
|
A
|
Ashtead Technology Holdings PLC
LSE:AT
|
UK |
|
I
|
Index Living Mall PCL
SET:ILM
|
TH |
|
Citi Trends Inc
NASDAQ:CTRN
|
US |
|
R
|
Ritamix Global Ltd
HKEX:1936
|
MY |
|
Zhejiang Runyang New Material Technology Co Ltd
SZSE:300920
|
CN |
|
Circassia Group PLC
LSE:CIR
|
UK |
|
E
|
Electronics Mart India Ltd
NSE:EMIL
|
IN |
Relative Value
The Relative Value of one
PRGO
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 9.69 USD,
Perrigo Company PLC
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PRGO Relative Value
HIDDEN
Multiples Across Competitors
PRGO Competitors Multiples
Perrigo Company PLC Competitors
Perrigo Company PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IE |
|
Perrigo Company PLC
NYSE:PRGO
|
1.3B USD | 0.3 | -0.9 | 6.8 | 14.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 13.3 | 41.9 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD | 4.5 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP | 5 | 28.6 | 15.9 | 22.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD | 2.5 | 16.8 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
